L01DC03 • mitomycin • Antineoplastic and immunomodulating agents | Cytotoxic antibiotics and related substances | Other cytotoxic antibiotics
Mitomicinum is a chemotherapy drug used for the treatment of certain types of cancer, including gastric cancer, pancreatic cancer, and bladder cancer. It acts as an alkylating agent, interfering with DNA synthesis in cancer cells and inhibiting their division.
The medication is administered intravenously or intravesically, depending on the type and location of the cancer. It is effective in reducing tumor size and slowing disease progression.
Side effects may include nausea, vomiting, bone marrow suppression, increased risk of infections, and, in rare cases, pulmonary or renal toxicity. Close monitoring is essential during treatment.
Consult your doctor to discuss the benefits and risks of treatment with Mitomicinum. This medication must be administered under the supervision of an oncology specialist.
Substance: mitomycin
Date of last drug list: 01-06-2016
Commercial code: W62644004
Concentration: 20mg
Pharmaceutical form: powder + solvent for intravesical solution
Quantity: 6
Product type: generic
Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).